J&J expects to hit $100 billion in revenue next year after new strategy pays off

BIAS: Center
RELIABILITY: Mixed
MarketWatch
12:26Z

Johnson & Johnson sees revenue grow 9% in the fourth quarter, amid strength in its cancer drugs.

Continue reading at the original source

Read Full Article at MarketWatch →